Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-02 6:51 pm Purchase | 2025-03-16 | 13G | Entera Bio Ltd. ENTX | OPKO HEALTH INC. OPK | 3,685,226 8.100% | 3,685,226 (New Position) | Filing History |
| 2025-01-06 4:10 pm Purchase | 2025-01-03 | 13G | Entera Bio Ltd. ENTX | Point72 Asset Management, L.P. | 2,701,560 6.800% | 2,701,560 (New Position) | Filing History |
| 2024-11-20 1:48 pm Purchase | 2024-11-14 | 13G | Entera Bio Ltd. ENTX | Knoll Capital Management LLC | 5,881,879 15.000% | 5,881,879 (New Position) | Filing History |
| 2024-08-20 06:01 am Unchanged | 2024-07-19 | 13G | Entera Bio Ltd. ENTX | CENTILLION FUND INC. | 2,396,953 6.700% | 0 (Unchanged) | Filing History |
| 2024-01-16 10:45 am Purchase | 2023-12-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Knoll Capital Management LLC | 3,881,879 9.967% | 3,799,070 (+4587.74%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Entera Bio Ltd. ENTX | RA Capital Management, L.P. | 295,966 1.000% | -2,057,034 (-87.42%) | Filing History |
| 2022-11-18 12:40 pm Purchase | 2022-08-31 | 13G | Entera Bio Ltd. ENTX | CENTILLION FUND INC. | 2,396,953 8.320% | 1,131,130 (+89.36%) | Filing History |
| 2022-11-17 6:36 pm Unchanged | 2022-08-31 | 13G | Entera Bio Ltd. ENTX | CENTILLION FUND INC. | 1,265,823 4.390% | 0 (Unchanged) | Filing History |
| 2022-11-17 6:34 pm Purchase | 2022-08-31 | 13G | Entera Bio Ltd. ENTX | CENTILLION FUND INC. | 1,265,823 4.390% | 134,693 (+11.91%) | Filing History |
| 2022-11-10 5:25 pm Unchanged | 2021-12-31 | 13G | Entera Bio Ltd. ENTX | CENTILLION FUND INC. | 1,131,130 3.930% | 0 (Unchanged) | Filing History |
| 2022-02-14 08:30 am Sale | 2021-12-31 | 13G | Entera Bio Ltd. ENTX | Capital Point Ltd. | 0 0.000% | -1,147,385 (Position Closed) | Filing History |
| 2021-06-30 4:33 pm Purchase | 2021-06-23 | 13G | Entera Bio Ltd. ENTX | RA Capital Management, L.P. | 2,353,000 9.900% | 2,353,000 (New Position) | Filing History |
| 2021-06-14 12:58 pm Purchase | 2021-05-19 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Knoll Capital Management LLC | 82,809 10.400% | 24,764 (+42.66%) | Filing History |
| 2021-02-16 2:48 pm Purchase | 2020-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Knoll Capital Management LLC | 58,045 8.300% | 58,045 (New Position) | Filing History |
| 2021-02-16 07:28 am Sale | 2020-12-31 | 13G | Entera Bio Ltd. ENTX | RAPHAEL MENAHEM EHUD ZOHAR | 1,390,997 6.512% | -84,240 (-5.71%) | Filing History |
| 2021-02-16 06:11 am Sale | 2020-12-31 | 13G | Entera Bio Ltd. ENTX | Capital Point Ltd. | 1,147,385 5.430% | -457,435 (-28.50%) | Filing History |
| 2021-02-10 4:12 pm Sale | 2020-12-31 | 13G | Entera Bio Ltd. ENTX | CENTILLION FUND INC. | 1,131,130 5.370% | -271,180 (-19.34%) | Filing History |